EUVIMEDEUVIMED entdecken
Systematische ÜbersichtUmbrella ReviewOpen Access · CC BY 4.0

Probiotics/synbiotics supplementation reduce the infection incidence in patients undergoing resection for colorectal cancer: an umbrella review

Shilin Gao, Xi Liao, Yuhua He, Jie Yang

Frontiers in Microbiology · 11.09.2025 · 16

DOI: 10.3389/fmicb.2025.1635409 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Microbiology, online erschienen am 11.09.2025. Verfasst von Shilin Gao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Colorectal Cancer Center, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study reviews meta-analyses of perioperative supplementation with probiotics/synbiotics in colorectal cancer (CRC), systematically assessing the quality of meta-analyses and synthesizing study results to provide robust evidence.

Methods

This review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement. The search was conducted by two authors in four databases, PubMed, CENTRAL, EMBASE and Web of Science, up until August 3rd, 2025, and conducted independent assessments of the methodological quality of the meta-analysis via A Measure Tool to Assess Systematic Reviews (AMSTAR) 2.

Results

A total of 11 meta-analyses were included in this umbrella review. 3 meta-analyses rated “Critically low” shared ≥3 critical flaws and 2 high-rated reviews adhered to ≥80% AMSTAR 2 criteria. Compared with the control group, the probiotic/synbiotic group presented lower incidence rates of overall infections (OR 0.49, 95% CI: 0.43, 0.56; P < 0. 001, I 2 = 6%), surgical site infections (OR 0.58, 95% CI: 0.50, 0.67; P < 0.00001, I 2 = 0%), urinary tract infections (OR 0.39, 95% CI: 0.27, 0.54; P < 0.00001, I 2 = 0%), and pneumonia infections (OR 0.34, 95% CI: 0.26, 0.45; P < 0.00001, I 2 = 0%), and diarrhea incidence (OR 0.41, 95% CI: 0.34, 0.51; P < 0.00001, I 2 = 0%).

Conclusion

According to the results of our analyses, perioperative probiotic/synbiotic supplementation in CRC patients is associated with a reduced incidence of overall infections, surgical site infections, urinary tract infections, pneumonia infections, and diarrhea. Systematic review registration https://www.crd.york.ac.uk/prospero/ , identifier CRD42024619853.

Schlagwörter

Stichwörter der Autor:innen

colorectal cancergut microbiotaprebioticprobioticsynbioticumbrella review

Autor:innen und Institutionen

  • Colorectal Cancer Center, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China.

Zitieren

APA

Gao, S., Liao, X., He, Y., & Yang, J. (2025). Probiotics/synbiotics supplementation reduce the infection incidence in patients undergoing resection for colorectal cancer: an umbrella review. Frontiers in Microbiology, 16. https://doi.org/10.3389/fmicb.2025.1635409

Vancouver

Gao S, Liao X, He Y, Yang J. Probiotics/synbiotics supplementation reduce the infection incidence in patients undergoing resection for colorectal cancer: an umbrella review. Frontiers in Microbiology. 2025;16. doi:10.3389/fmicb.2025.1635409

BibTeX
@article{Gao2025,
  author = {Gao, Shilin and Liao, Xi and He, Yuhua and Yang, Jie},
  title = {Probiotics/synbiotics supplementation reduce the infection incidence in patients undergoing resection for colorectal cancer: an umbrella review},
  journal = {Frontiers in Microbiology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fmicb.2025.1635409}
}
Kostenlos starten →